Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2025-12-25 @ 12:18 AM
NCT ID:
NCT01456858
Eligibility Criteria:
Inclusion Criteria:
* Resident of LARGO or TOBANDA Refugee Camp, Sierra Leone, West Africa
* Child whose guardian has given informed consent for their child to be enrolled into monitoring
* Child aged 4 months to 3 years
Exclusion Criteria:
* Residents who answer "Yes" to the question, "Do you anticipate/plan on moving out of this shelter or camp in the next 6-12 months?"
* Children who have a serious illness other than malaria, based on guardian report.
* Children who have experienced adverse reactions to Amodiaquine or Artesunate on a previous occasion.
* Guardians of children who answer "Yes" to the question, "Do you anticipate/plan on moving out of this shelter or camp in the next 12 months?"
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
4 Months
Maximum Age:
36 Months
Study:
NCT01456858
Study Brief:
Protocol Section:
NCT01456858